Drug interactions are common among older adults receiving antiretroviral therapies
KEY POINT
A cross-sectional observational study published in the Journal of Acquired Immune Deficiency Syndromes involving 744 patients with HIV receiving antiretroviral treatment and at least one nonantiretroviral medication showed that more than one-half of these patients had at least one or more potential drug–drug interactions (DDIs), with a higher risk of interactions observed for those receiving five or more medications.
SOURCES
Ranzani A, et al. Burden of exposure to potential interactions between antiretroviral and non-antiretroviral medications in a population of HIV-positive patients aged 50 years or older. J Acquir Immune Defic Syndr. 2018;78(2):193–201.
